NPI: 1932176484 · DELAND, FL 32724 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/03/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/03/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,591 | $2.51M |
| 2019 | 21,723 | $3.85M |
| 2020 | 26,568 | $3.69M |
| 2021 | 20,954 | $1.66M |
| 2022 | 12,077 | $1.68M |
| 2023 | 2,921 | $277K |
| 2024 | 863 | $37K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 32,063 | 2,119 | $4.94M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 29,424 | 1,365 | $3.58M |
| J2501 | Injection, paricalcitol, 1 mcg | 20,937 | 982 | $2.67M |
| J1756 | Injection, iron sucrose, 1 mg | 6,294 | 1,255 | $670K |
| A4657 | Syringe, with or without needle, each | 2,643 | 1,495 | $513K |
| 85041 | 1,722 | 1,221 | $231K | |
| 85048 | 1,675 | 1,192 | $226K | |
| 83970 | 1,457 | 800 | $200K | |
| 85045 | 1,286 | 929 | $157K | |
| 83550 | 914 | 680 | $123K | |
| 83540 | 911 | 677 | $123K | |
| 82728 | 813 | 607 | $111K | |
| 82108 | 581 | 432 | $76K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 198 | 127 | $25K |
| 90674 | 88 | 67 | $16K | |
| 82746 | 144 | 108 | $14K | |
| 82607 | 136 | 100 | $11K | |
| G0008 | Administration of influenza virus vaccine | 38 | 35 | $8K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 48 | 25 | $7K |
| 90662 | 17 | 12 | $2K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 308 | 28 | $0.00 |